David C Jamora, MD - Medicare Family Practice in Hopkinsville, KY

David C Jamora, MD is a medicare enrolled "Family Medicine" physician in Hopkinsville, Kentucky. He graduated from medical school in 2012 and has 12 years of diverse experience with area of expertise as Family Practice. He is a member of the group practice Baptist Health Deaconess Medical Group Inc and his current practice location is 500 Clinic Dr, Hopkinsville, Kentucky. You can reach out to his office (for appointments etc.) via phone at (270) 707-3329.

David C Jamora is licensed to practice in Kentucky (license number 47387) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1538420666.

Contact Information

David C Jamora, MD
500 Clinic Dr,
Hopkinsville, KY 42240-4991
(270) 707-3329
(270) 707-3335



Physician's Profile

Full NameDavid C Jamora
GenderMale
SpecialityFamily Practice
Experience12 Years
Location500 Clinic Dr, Hopkinsville, Kentucky
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • David C Jamora graduated from medical school in 2012
  NPI Data:
  • NPI Number: 1538420666
  • Provider Enumeration Date: 06/05/2012
  • Last Update Date: 12/07/2020
  Medicare PECOS Information:
  • PECOS PAC ID: 5597995027
  • Enrollment ID: I20140303001199

Medical Identifiers

Medical identifiers for David C Jamora such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1538420666NPI-NPPES
7100274430MedicaidKY

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Q00000XFamily Medicine 47387 (Kentucky)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Baptist Health MadisonvilleMadisonville, KYHospital
Jennie Stuart Medical CenterHopkinsville, KYHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Baptist Health Deaconess Medical Group Inc6103220330126

News Archive

Montelukast improves respiratory disturbance and adenoid size in children with OSA

Ben-Gurion University of the Negev (BGU) researchers revealed that a majority of children suffering from Obstructive Sleep Apnea (OSA) treated with montelukast, a drug approved for asthma or hay fever, showed significant improvement in respiratory disturbance and adenoid size, according to a new study published in Pediatrics Journal.

EntreMed commences Phase 2 study of ENMD-2076 for platinum resistant ovarian cancer

EntreMed, Inc. today announced the initiation of a multi-center Phase 2 study with its lead oncology product candidate, ENMD-2076, in patients with platinum resistant ovarian cancer. The study will be conducted at up to six sites in the United States and Canada. In addition, EntreMed received a No Objection Letter (NOL) from the Therapeutic Products Directorate of Health Canada on its Clinical Trial Application to conduct the Phase 2 clinical trial in ovarian cancer patients.

Epic Wound Care enters beta test agreement with Ryan Network for UEEC's hemostatic gauze

United Health Products, Inc.'s www.unitedhealthproductsinc.com wholly owned subsidiary, Epic Wound Care, Inc., which develops and markets products and technologies in the healthcare sector, is pleased to announce that it has entered into a beta test agreement with the distinguished Ryan Network for UEEC's hemostatic gauze. The gauze is registered and branded in the USA under the trademark HemoStyp.

Scientists aim to mislead malaria mosquitoes with odours

An international team of scientists will in the coming five years set up a research project on developing diversions to mislead malaria mosquitoes with odours.

Researchers identify molecular emergency brake in charge of regulating self-digestion

Almost everything that happens inside a cell, including autophagy, is tightly regulated on a biochemical level. Like that, the cell makes sure that processes only take place when they are needed and that they are shut off when the need has expired. "Inside the cell, there exists a network of molecules. Between them, information is constantly being exchanged," says Schmitz, head of the research group "Systems-oriented Immunology and Inflammation Research" at HZI, who also holds a chair at the Otto von Guericke University in Magdeburg.

Read more Medical News

› Verified 6 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. David C Jamora allows following entities to bill medicare on his behalf.
Entity NameBaptist Health Medical Group Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1740586213
PECOS PAC ID: 5597867184
Enrollment ID: O20070228000503

News Archive

Montelukast improves respiratory disturbance and adenoid size in children with OSA

Ben-Gurion University of the Negev (BGU) researchers revealed that a majority of children suffering from Obstructive Sleep Apnea (OSA) treated with montelukast, a drug approved for asthma or hay fever, showed significant improvement in respiratory disturbance and adenoid size, according to a new study published in Pediatrics Journal.

EntreMed commences Phase 2 study of ENMD-2076 for platinum resistant ovarian cancer

EntreMed, Inc. today announced the initiation of a multi-center Phase 2 study with its lead oncology product candidate, ENMD-2076, in patients with platinum resistant ovarian cancer. The study will be conducted at up to six sites in the United States and Canada. In addition, EntreMed received a No Objection Letter (NOL) from the Therapeutic Products Directorate of Health Canada on its Clinical Trial Application to conduct the Phase 2 clinical trial in ovarian cancer patients.

Epic Wound Care enters beta test agreement with Ryan Network for UEEC's hemostatic gauze

United Health Products, Inc.'s www.unitedhealthproductsinc.com wholly owned subsidiary, Epic Wound Care, Inc., which develops and markets products and technologies in the healthcare sector, is pleased to announce that it has entered into a beta test agreement with the distinguished Ryan Network for UEEC's hemostatic gauze. The gauze is registered and branded in the USA under the trademark HemoStyp.

Scientists aim to mislead malaria mosquitoes with odours

An international team of scientists will in the coming five years set up a research project on developing diversions to mislead malaria mosquitoes with odours.

Researchers identify molecular emergency brake in charge of regulating self-digestion

Almost everything that happens inside a cell, including autophagy, is tightly regulated on a biochemical level. Like that, the cell makes sure that processes only take place when they are needed and that they are shut off when the need has expired. "Inside the cell, there exists a network of molecules. Between them, information is constantly being exchanged," says Schmitz, head of the research group "Systems-oriented Immunology and Inflammation Research" at HZI, who also holds a chair at the Otto von Guericke University in Magdeburg.

Read more Medical News

› Verified 6 days ago

Entity NameBaptist Health Medical Group Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1922401611
PECOS PAC ID: 5597867184
Enrollment ID: O20150219000942

News Archive

Montelukast improves respiratory disturbance and adenoid size in children with OSA

Ben-Gurion University of the Negev (BGU) researchers revealed that a majority of children suffering from Obstructive Sleep Apnea (OSA) treated with montelukast, a drug approved for asthma or hay fever, showed significant improvement in respiratory disturbance and adenoid size, according to a new study published in Pediatrics Journal.

EntreMed commences Phase 2 study of ENMD-2076 for platinum resistant ovarian cancer

EntreMed, Inc. today announced the initiation of a multi-center Phase 2 study with its lead oncology product candidate, ENMD-2076, in patients with platinum resistant ovarian cancer. The study will be conducted at up to six sites in the United States and Canada. In addition, EntreMed received a No Objection Letter (NOL) from the Therapeutic Products Directorate of Health Canada on its Clinical Trial Application to conduct the Phase 2 clinical trial in ovarian cancer patients.

Epic Wound Care enters beta test agreement with Ryan Network for UEEC's hemostatic gauze

United Health Products, Inc.'s www.unitedhealthproductsinc.com wholly owned subsidiary, Epic Wound Care, Inc., which develops and markets products and technologies in the healthcare sector, is pleased to announce that it has entered into a beta test agreement with the distinguished Ryan Network for UEEC's hemostatic gauze. The gauze is registered and branded in the USA under the trademark HemoStyp.

Scientists aim to mislead malaria mosquitoes with odours

An international team of scientists will in the coming five years set up a research project on developing diversions to mislead malaria mosquitoes with odours.

Researchers identify molecular emergency brake in charge of regulating self-digestion

Almost everything that happens inside a cell, including autophagy, is tightly regulated on a biochemical level. Like that, the cell makes sure that processes only take place when they are needed and that they are shut off when the need has expired. "Inside the cell, there exists a network of molecules. Between them, information is constantly being exchanged," says Schmitz, head of the research group "Systems-oriented Immunology and Inflammation Research" at HZI, who also holds a chair at the Otto von Guericke University in Magdeburg.

Read more Medical News

› Verified 6 days ago

Entity NameBaptist Health Deaconess Medical Group Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1437730942
PECOS PAC ID: 6103220330
Enrollment ID: O20210810000993

News Archive

Montelukast improves respiratory disturbance and adenoid size in children with OSA

Ben-Gurion University of the Negev (BGU) researchers revealed that a majority of children suffering from Obstructive Sleep Apnea (OSA) treated with montelukast, a drug approved for asthma or hay fever, showed significant improvement in respiratory disturbance and adenoid size, according to a new study published in Pediatrics Journal.

EntreMed commences Phase 2 study of ENMD-2076 for platinum resistant ovarian cancer

EntreMed, Inc. today announced the initiation of a multi-center Phase 2 study with its lead oncology product candidate, ENMD-2076, in patients with platinum resistant ovarian cancer. The study will be conducted at up to six sites in the United States and Canada. In addition, EntreMed received a No Objection Letter (NOL) from the Therapeutic Products Directorate of Health Canada on its Clinical Trial Application to conduct the Phase 2 clinical trial in ovarian cancer patients.

Epic Wound Care enters beta test agreement with Ryan Network for UEEC's hemostatic gauze

United Health Products, Inc.'s www.unitedhealthproductsinc.com wholly owned subsidiary, Epic Wound Care, Inc., which develops and markets products and technologies in the healthcare sector, is pleased to announce that it has entered into a beta test agreement with the distinguished Ryan Network for UEEC's hemostatic gauze. The gauze is registered and branded in the USA under the trademark HemoStyp.

Scientists aim to mislead malaria mosquitoes with odours

An international team of scientists will in the coming five years set up a research project on developing diversions to mislead malaria mosquitoes with odours.

Researchers identify molecular emergency brake in charge of regulating self-digestion

Almost everything that happens inside a cell, including autophagy, is tightly regulated on a biochemical level. Like that, the cell makes sure that processes only take place when they are needed and that they are shut off when the need has expired. "Inside the cell, there exists a network of molecules. Between them, information is constantly being exchanged," says Schmitz, head of the research group "Systems-oriented Immunology and Inflammation Research" at HZI, who also holds a chair at the Otto von Guericke University in Magdeburg.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. David C Jamora is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
David C Jamora, MD
500 Clinic Dr,
Hopkinsville, KY 42240-4991

Ph: (270) 707-3329
David C Jamora, MD
500 Clinic Dr,
Hopkinsville, KY 42240-4991

Ph: (270) 707-3329

News Archive

Montelukast improves respiratory disturbance and adenoid size in children with OSA

Ben-Gurion University of the Negev (BGU) researchers revealed that a majority of children suffering from Obstructive Sleep Apnea (OSA) treated with montelukast, a drug approved for asthma or hay fever, showed significant improvement in respiratory disturbance and adenoid size, according to a new study published in Pediatrics Journal.

EntreMed commences Phase 2 study of ENMD-2076 for platinum resistant ovarian cancer

EntreMed, Inc. today announced the initiation of a multi-center Phase 2 study with its lead oncology product candidate, ENMD-2076, in patients with platinum resistant ovarian cancer. The study will be conducted at up to six sites in the United States and Canada. In addition, EntreMed received a No Objection Letter (NOL) from the Therapeutic Products Directorate of Health Canada on its Clinical Trial Application to conduct the Phase 2 clinical trial in ovarian cancer patients.

Epic Wound Care enters beta test agreement with Ryan Network for UEEC's hemostatic gauze

United Health Products, Inc.'s www.unitedhealthproductsinc.com wholly owned subsidiary, Epic Wound Care, Inc., which develops and markets products and technologies in the healthcare sector, is pleased to announce that it has entered into a beta test agreement with the distinguished Ryan Network for UEEC's hemostatic gauze. The gauze is registered and branded in the USA under the trademark HemoStyp.

Scientists aim to mislead malaria mosquitoes with odours

An international team of scientists will in the coming five years set up a research project on developing diversions to mislead malaria mosquitoes with odours.

Researchers identify molecular emergency brake in charge of regulating self-digestion

Almost everything that happens inside a cell, including autophagy, is tightly regulated on a biochemical level. Like that, the cell makes sure that processes only take place when they are needed and that they are shut off when the need has expired. "Inside the cell, there exists a network of molecules. Between them, information is constantly being exchanged," says Schmitz, head of the research group "Systems-oriented Immunology and Inflammation Research" at HZI, who also holds a chair at the Otto von Guericke University in Magdeburg.

Read more News

› Verified 6 days ago


Family Medicine Doctors in Hopkinsville, KY

Kari Howton, APRN
Family Medicine
Medicare: Medicare Enrolled
Practice Location: 1724 Kenton St Ste 1d, Hopkinsville, KY 42240
Phone: 270-887-9066    Fax: 270-887-9199
Alan D Cato, MD
Family Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 2400 Russellville Rd, Hopkinsville, KY 42240
Phone: 270-889-6025    Fax: 270-886-4487
Dr. Panagiotis Galanopoulos, M.D.
Family Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 3999 Fort Campbell Blvd, Hopkinsville, KY 42240
Phone: 270-886-2205    Fax: 270-886-0392
Vinna R Denison, MD
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 320 North Dr, Hopkinsville, KY 42240
Phone: 270-707-0303    Fax: 270-707-0808
Billy Kevin Fralish, MD
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 500 Clinic Dr, Hopkinsville, KY 42240
Phone: 270-707-3300    
Dr. William E Sweet, M.D.
Family Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 1102 S Virginia St, Hopkinsville, KY 42240
Phone: 270-890-0440    Fax: 270-890-0449
Chester L Crump, MD
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1717 High St, Suite 2d, Hopkinsville, KY 42240
Phone: 270-885-6101    Fax: 270-885-3563

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.